3Shulman RW, Singh A, Shulman KI, et al. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacology Bulletin, 1997,33 (1) :113 - 117.
4Hollander E, Bienstock CA, Koran LM. Refractory obsessive-compulsive disorder state-of-the-art treatment. J Clin Psychiatry, 2002,63(Suppl 6) :20 -29.
5Wirshing DA, Pierre JM, Erhart SM, et al, Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psychiat Clin North Am,2003,26(1) :165 - 190.
6Laloude P. Evaluating antipsychotic medications:predictors of clinical effectiveness. Can J Psychiat,2003,48 (Suppl 3) :4 -12.
7Swann AC. Neuroreceptor mechanisms of aggression and its treatment.J Clin Psychiatry,2003,64(Suppl 4) :26 - 35.
9Green AI,Canso CM,Brenner MJ,et al. Detection and management of comorbidity in patients with schizophrenia. Psychiat Clin North Am,2003,26(1) :115 - 139.
10Kopala LC, Good KP, Koczapski AB, et al. Olfactory deficits in patients with schizophrenia and severe polydipsia. Biol Psychiatry, 1998,43(5) :497 -502.
